Hôpital Pitié Salpêtrière - AP-HP

104 currently recruiting clinical trials
Create patient profile for matching
Phase 1 Prostate cancer #NCT05983432 #2023-506539-14-00
Cohorte cancer de la prostate métastatique résistant à la castration
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic Castration-resistant
Required number of previous lines of therapy for current stage of disease
1
Required previous treatments at advanced or metastatic stage
Hormone therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive Chemotherapy
Hôpital Pitié Salpêtrière - AP-HP (Paris)
SystImmune Inc.
Phase 1 Ovarian / Fallopian tubes / Peritoneum cancer #NCT05983432 #2023-506539-14-00
Cohorte adénocarcinome ovarien
Required histologic types
Epithelial ovarian cancer Fallopian tube cancer Primary peritoneal cancer (PPC)
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
1
Required previous treatments at advanced or metastatic stage
Chemotherapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
SystImmune Inc.
Phase 1 Breast cancer #NCT05983432 #2023-506539-14-00
Cohortes cancer du sein
Required HER2 statuses
HER2 Negative HER2 Low
Required HR statuses
HR Negative HR Positive
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
1 2
Required previous treatments at advanced or metastatic stage
Immunotherapy Chemotherapy Targeted therapy Hormone therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Phase 1 Endometrial cancer #NCT05983432 #2023-506539-14-00
Cohorte cancer de l'endomètre
Required histologic sub types
Endometrioid adenocarcinoma Serous adenocarcinoma Clear cell carcinoma Dedifferentiated and undifferentiated endometrial ... Carcinosarcoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
1
Required previous treatments at advanced or metastatic stage
Chemotherapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
SystImmune Inc.
Phase 1 Lung cancer #NCT05983432 #2023-506539-14-00
Cohorte CPNPC EGFR muté
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required disease stage
Locally Advanced Metastatic
Required genetic anomalies
EGFR
Required number of previous lines of therapy for current stage of disease
1 2
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
SystImmune Inc.
Phase 1 Lung cancer #NCT05983432 #2023-506539-14-00
Cohorte CBNPC EGFR de type sauvage
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
1
Required previous treatments at advanced or metastatic stage
Immunotherapy Chemotherapy
Excluded genetic anomalies
ALK EGFR ROS-1
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
SystImmune Inc.
Phase 1 Kidney cancer #NCT06026410
Bras 2 CCR localement avancé ou métastatique
Required histologic types
Clear cell carcinoma Papillary carcinoma Chromophobe carcinoma Other
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
None 1 2 3 or more
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Kura Oncologie, Inc.
Not Applicable Liver and bile duct cancer #NCT04935853
Required histologic sub types
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma
Hôpital Pitié Salpêtrière - AP-HP (Paris)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Not Applicable Lung cancer #NCT06053099
Single Cohort
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required disease stage
Localized
Required genetic anomalies
EGFR
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive Surgery
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Intergroupe Francophone de Cancérologie Thoracique
Not Applicable Pancreas cancer Stomach and esophageal cancer #NCT05443087
Required histologic sub types
Neuroendocrine tumor
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
UNICANCER